Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.91B | 2.56B | 3.11B | 2.49B | 2.35B |
| Total Receivables | 3.37B | 3.31B | 2.80B | 3.14B | 3.08B |
| Inventory | 1.58B | 1.49B | 1.76B | 1.62B | 1.48B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 261.24M | 318.85M | 244.08M | 317.29M | 234.08M |
| Total Current Assets | 8.13B | 7.67B | 7.91B | 7.56B | 7.15B |
|
|
|||||
| Total Current Assets | 8.13B | 7.67B | 7.91B | 7.56B | 7.15B |
| Net Property, Plant & Equipment | 1.13B | 1.10B | 1.09B | 1.12B | 1.07B |
| Long-term Investments | 116.43M | 114.94M | 113.83M | 118.45M | 114.33M |
| Goodwill | 116.43M | 114.94M | 113.83M | 118.45M | 114.33M |
| Total Other Intangibles | 392.49M | 389.55M | 387.55M | 405.15M | 393.03M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 286.78M | 291.74M | 298.21M | 296.32M | 290.81M |
| Total Assets | 11.51B | 11.03B | 11.19B | 11.30B | 10.73B |
|
|
|||||
| Total Accounts Payable | 2.44B | 2.26B | 2.24B | 2.33B | 2.10B |
| Total Accrued Expenses | 529.34M | 114.57M | 503.17M | 149.76M | 536.62M |
| Short-term Debt | 1.43B | 1.24B | 1.25B | 1.34B | 1.27B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 365.86M | 409.72M | 208.60M | 205.09M | 116.92M |
| Total Finance Division Other Current Liabilities | 513.26M | 949.27M | 1.13B | 1.14B | 684.10M |
| Total Other Current Liabilities | 513.26M | 949.27M | 1.13B | 1.14B | 684.10M |
| Total Current Liabilities | 5.28B | 4.98B | 5.33B | 5.17B | 4.71B |
|
|
|||||
| Total Current Liabilities | 5.28B | 4.98B | 5.33B | 5.17B | 4.71B |
| Long-Term Debt | 360.22M | 289.11M | 384.37M | 377.10M | 447.93M |
| Short-term Debt | 1.43B | 1.24B | 1.25B | 1.34B | 1.27B |
| Capital Leases | 58.55M | 61.12M | 61.06M | 73.03M | 74.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 244.17M | 242.34M | 239.35M | 254.39M | 249.10M |
| Total Liabilities | 5.95B | 5.57B | 6.02B | 5.87B | 5.48B |
|
|
|||||
| Common Stock & APIC | 1.64B | 1.62B | 1.61B | 1.67B | 1.62B |
| Retained Earnings | 3.64B | 3.58B | 3.31B | 3.49B | 3.38B |
| Treasury Stock & Other | -3.23M | -2.84M | -1.90M | -2.77M | -2.66M |
| Total Common Equity | 5.27B | 5.20B | 4.92B | 5.16B | 4.99B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.27B | 5.20B | 4.92B | 5.16B | 4.99B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 286.31M | 264.57M | 255.53M | 260.98M | 254.91M |
| Total Equity | 5.56B | 5.46B | 5.17B | 5.42B | 5.25B |
|
|
|||||